Contemporary Management of HIV: New Data From CROI 2017
Source: Contemporary Management of HIV

Slideset

Contemporary Management of HIV: New Data From CROI 2017

In this downloadable slideset, Charles B. Hicks, MD, and Program Director Joseph J. Eron, Jr., MD, review key new HIV data presented at the Seattle 2017 meeting.

Topics include:
-Prevention
-New data on currently available ART
-Switch/simplification strategies for virologically suppressed patients
-Investigational ARV agents
-Treatment complications and comorbidities
Format: Microsoft PowerPoint (.ppt)
File size: 1.71 MB
Date posted: 4/26/2017
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017    1 comment / Last Comment: 6/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017    
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had history of nonadherence and resistance?
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017    
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017    
    For a newly-diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017    
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?